Internal Medicine, Infectious Disease · Jamaica, NY
NPI
1780763664
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
8268 164th St, Queens Hospital Center, Department of Medicine
Jamaica, NY, 11432
Phone (718) 883-4050
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
1,328 prescriptions
Company payments, 2024
$50.26
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Charles R Berman prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 117 prescriptions and refills. In total Charles R Berman wrote 1,328 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 117 | 121 | 15 | $470K |
| Tivicay Dolutegravir Sodium | 105 | 141 | 14 | $305K |
| Amlodipine Besylate Generic | 102 | 200 | 22 | $456 |
| Descovy Emtricitabine/Tenofov Alafenam | 90 | 114 | Under 11 | $238K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 68 | 76 | Under 11 | $281K |
| Ritonavir Generic | 44 | 58 | Under 11 | $6,465 |
| Atorvastatin Calcium Generic | 44 | 110 | 15 | $484 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 42 | 67 | Under 11 | $58K |
| Isentress Raltegravir Potassium | 39 | 47 | Under 11 | $88K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 36 | 49 | Under 11 | $1,376 |
| Darunavir Generic | 28 | 28 | Under 11 | $18K |
| Valacyclovir Valacyclovir Hcl | 25 | 41 | Under 11 | $1,581 |
| Hydrochlorothiazide Generic | 21 | 43 | Under 11 | $98.23 |
| Gabapentin Generic | 21 | 32 | Under 11 | $189 |
| Rosuvastatin Calcium Generic | 21 | 41 | Under 11 | $158 |
Brand drugs: - claims; generic drugs: 718 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Charles R Berman $50.26 ($50.26 in general payments such as food, travel and fees) from 2 companies. The largest payer was Meridian Bioscience Inc. with $34.27.
| Company | Payments | Amount |
|---|---|---|
| Meridian Bioscience Inc. | 1 | $34.27 |
| Pfizer Inc. PFE | 1 | $15.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.